Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

gan Kalberg, Chris, O’Dell, Dianne, Galkin, Dmitry, Newlands, Amy, Fahy, William A.
Cyhoeddwyd yn Drugs R D (2016)

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD

gan Rheault, Tara, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A.
Cyhoeddwyd yn ERJ Open Res (2016)

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

gan Siler, Thomas M, Donald, Alison C, O’Dell, Dianne, Church, Alison, Fahy, William A
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2016)

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

gan Singh, Dave, Maleki-Yazdi, M Reza, Tombs, Lee, Iqbal, Ahmar, Fahy, William A, Naya, Ian
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2016)

Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials

gan Maleki-Yazdi, M. Reza, Singh, Dave, Anzueto, Antonio, Tombs, Lee, Fahy, William A., Naya, Ian
Cyhoeddwyd yn Adv Ther (2016)

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD

gan Feldman, Gregory, Maltais, François, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A, Trivedi, Roopa
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2016)

The effect of umeclidinium added to inhaled corticosteroid/long-acting β(2)-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

gan Sousa, Ana R, Riley, John H, Church, Alison, Zhu, Chang-Qing, Punekar, Yogesh S, Fahy, William A
Cyhoeddwyd yn NPJ Prim Care Respir Med (2016)

Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort

gan Meeraus, Wilhelmine H, Mullerova, Hana, El Baou, Céline, Fahey, Marion, Hessel, Edith M, Fahy, William A
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2021)

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD

gan Singh, Sally, Maltais, François, Tombs, Lee, Fahy, William A, Vahdati-Bolouri, Mitra, Locantore, Nicholas, Riley, John H
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2018)

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

gan Kerwin, Edward M, Kalberg, Chris J, Galkin, Dmitry V, Zhu, Chang-Qing, Church, Alison, Riley, John H, Fahy, William A
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2017)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

gan Usmani, Omar S., Biddiscombe, Martyn F., Yang, Shuying, Meah, Sally, Oballa, Eunice, Simpson, Juliet K., Fahy, William A., Marshall, Richard P., Lukey, Pauline T., Maher, Toby M.
Cyhoeddwyd yn Respir Res (2018)

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis

gan Stewart, Iain D., Nanji, Henry, Figueredo, Grazziela, Fahy, William A., Maher, Toby M., Ask, Antje J., Maharaj, Shyam, Ask, Kjetil, Kolb, Martin, Jenkins, Gisli R.
Cyhoeddwyd yn Eur Respir J (2021)

BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

gan Molyneaux, Philip L., Smith, Jonathan J., Saunders, Peter, Chua, Felix, Wells, Athol U., Renzoni, Elisabetta A., Nicholson, Andrew G., Fahy, William A., Jenkins, R. Gisli, Maher, Toby M.
Cyhoeddwyd yn Am J Respir Crit Care Med (2021)

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study

gan Fahy, William A, Homayoun-Valiani, Farshid, Cahn, Anthony, Robertson, Jon, Templeton, Alison, Meeraus, Wilhelmine H, Wilson, Robert, Lowings, Mike, Marotti, Miriam, West, Sarah L, Tabberer, Maggie, Hessel, Edith M
Cyhoeddwyd yn Int J Chron Obstruct Pulmon Dis (2021)

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants

gan Maden, Charlotte H., Fairman, David, Chalker, Michelle, Costa, Maria J., Fahy, William A., Garman, Nadia, Lukey, Pauline T., Mant, Tim, Parry, Simon, Simpson, Juliet K., Slack, Robert J., Kendrick, Stuart, Marshall, Richard P.
Cyhoeddwyd yn Eur J Clin Pharmacol (2018)

Clinical quantification of the integrin αvβ6 by [(18)F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)

gan Lukey, Pauline T., Coello, Christopher, Gunn, Roger, Parker, Christine, Wilson, Frederick J., Saleem, Azeem, Garman, Nadia, Costa, Maria, Kendrick, Stuart, Onega, Mayca, Kang’ombe, Arthur R., Listanco, Allan, Davies, James, Ramada-Magalhaes, Joaquim, Moz, Sara, Fahy, William A., Maher, Toby M., Jenkins, Gisli, Passchier, Jan, Marshall, Richard P.
Cyhoeddwyd yn Eur J Nucl Med Mol Imaging (2019)

Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome

gan Nayar, Saba, Campos, Joana, Smith, Charlotte G, Iannizzotto, Valentina, Gardner, David H, Colafrancesco, Serena, Pipi, Elena, Kollert, Florian, Hunter, Kelly J, Brewer, Charlotte, Buckley, Christopher Dominic, Bowman, Simon J, Priori, Roberta, Valesini, Guido, Juarez, Maria, Fahy, William A, Fisher, Benjamin A, Payne, Andrew, Allen, Rodger A, Barone, Francesca
Cyhoeddwyd yn Ann Rheum Dis (2019)

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

gan Organ, Louise A., Duggan, Anne-Marie R., Oballa, Eunice, Taggart, Sarah C., Simpson, Juliet K., Kang’ombe, Arthur R., Braybrooke, Rebecca, Molyneaux, Philip L., North, Bernard, Karkera, Yakshitha, Leeming, Diana J., Karsdal, Morten A., Nanthakumar, Carmel B., Fahy, William A., Marshall, Richard P., Jenkins, R. Gisli, Maher, Toby M.
Cyhoeddwyd yn Respir Res (2019)

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ...

gan Maher, Toby M., Simpson, Juliet K., Porter, Joanna C., Wilson, Frederick J., Chan, Robert, Eames, Rhena, Cui, Yi, Siederer, Sarah, Parry, Simon, Kenny, Julia, Slack, Robert J., Sahota, Jagdeep, Paul, Lyn, Saunders, Peter, Molyneaux, Philip L., Lukey, Pauline T., Rizzo, Gaia, Searle, Graham E., Marshall, Richard P., Saleem, Azeem, Kang’ombe, Arthur R., Fairman, David, Fahy, William A., Vahdati-Bolouri, Mitra
Cyhoeddwyd yn Respir Res (2020)

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

gan Allen, Richard J, Porte, Joanne, Braybrooke, Rebecca, Flores, Carlos, Fingerlin, Tasha E, Oldham, Justin M, Guillen-Guio, Beatriz, Ma, Shwu-Fan, Okamoto, Tsukasa, John, Alison E, Obeidat, Ma'en, Yang, Ivana V, Henry, Amanda, Hubbard, Richard B, Navaratnam, Vidya, Saini, Gauri, Thompson, Norma, Booth, Helen L, Hart, Simon P, Hill, Mike R, Hirani, Nik, Maher, Toby M, McAnulty, Robin J, Millar, Ann B, Molyneaux, Philip L, Parfrey, Helen, Rassl, Doris M, Whyte, Moira K B, Fahy, William A, Marshall, Richard P, Oballa, Eunice, Bossé, Yohan, Nickle, David C, Sin, Don D, Timens, Wim, Shrine, Nick, Sayers, Ian, Hall, Ian P, Noth, Imre, Schwartz, David A, Tobin, Martin D, Wain, Louise V, Jenkins, R Gisli
Cyhoeddwyd yn Lancet Respir Med (2017)